Telangana: Aurobindo Pharma has announced in a BSE filing that the US Food and Drug Administration (USFDA) has concluded inspection with 2 observations at Unit-V of Apitoria Pharma Private Limited, a ...

Aurobindo Pharma's shares rose 2% after the US FDA completed an inspection of its subsidiary's API manufacturing facility with two procedural observations. The company reported an 8.6% YoY rise in Q2 ...

Aurobindo Pharma's share price is trading higher on December 18 despite the recent news of receiving two observations from the United States Food and Drug Administration (USFDA). At 09:22am ...

Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of ...

Aurobindo Pharma's subsidiary, Apitoria Pharma, received two procedural observations from the USFDA after an inspection of its Telangana API manufacturing facility. The company stated it will ...

Aurobindo Pharma subsidiary Apitoria Pharma’s active pharmaceutical ingredients manufacturing facility near Hyderabad has been issued two observations by the U.S. Food and Drug Administration ...

Pharmaceutical company Aurobindo Pharma Ltd on Tuesday (December 17) announced that the United States Food and Drug Administration (FDA) completed an inspection of Unit-V, an active pharmaceutical ...

Use an OTC nasal decongestant spray 30 minutes before takeoff and landing. If you suspect that there is a foreign object inside your ear canal, do not try to remove it yourself. Go to the nearest ...

People may only be able to breathe through one nostril due to congestion, allergies, a blockage, or natural changes in the nasal cycle. This is not uncommon and may get better on its own.

Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of US ...

Aurobindo Pharma subsidiary CuraTeQ Biologics has received positive opinion for Zefylti, its biosimilar of filgrastim, from the Committee for Medicinal Products for Human Use (CHMP) of the ...